359 related articles for article (PubMed ID: 20031488)
1. Simultaneous analysis of ochratoxin A and its major metabolite ochratoxin alpha in plasma and urine for an advanced biomonitoring of the mycotoxin.
Muñoz K; Blaszkewicz M; Degen GH
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Oct; 878(27):2623-9. PubMed ID: 20031488
[TBL] [Abstract][Full Text] [Related]
2. Ochratoxin A and its metabolite ochratoxin alpha in urine and assessment of the exposure of inhabitants of Lleida, Spain.
Coronel MB; Marin S; Tarragó M; Cano-Sancho G; Ramos AJ; Sanchis V
Food Chem Toxicol; 2011 Jun; 49(6):1436-42. PubMed ID: 21443919
[TBL] [Abstract][Full Text] [Related]
3. Quantitative determination of mycotoxins in urine by LC-MS/MS.
Ahn J; Kim D; Kim H; Jahng KY
Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2010 Dec; 27(12):1674-82. PubMed ID: 20818517
[TBL] [Abstract][Full Text] [Related]
4. Ochratoxin A and its metabolites in urines of German adults-An assessment of variables in biomarker analysis.
Ali N; Muñoz K; Degen GH
Toxicol Lett; 2017 Jun; 275():19-26. PubMed ID: 28445738
[TBL] [Abstract][Full Text] [Related]
5. A direct assessment of mycotoxin biomarkers in human urine samples by liquid chromatography tandem mass spectrometry.
Ediage EN; Di Mavungu JD; Song S; Wu A; Van Peteghem C; De Saeger S
Anal Chim Acta; 2012 Sep; 741():58-69. PubMed ID: 22840705
[TBL] [Abstract][Full Text] [Related]
6. Liquid chromatographic methods for biotransformation studies of ochratoxin A.
Schaut A; De Saeger S; Sergent T; Schneider YJ; Larondelle Y; Pussemier L; Blank R; Van Peteghem C
Biomed Chromatogr; 2008 Sep; 22(9):1013-20. PubMed ID: 18506683
[TBL] [Abstract][Full Text] [Related]
7. Estimation of ochratoxin A in portuguese population: new data on the occurrence in human urine by high performance liquid chromatography with fluorescence detection.
Pena A; Seifrtová M; Lino C; Silveira I; Solich P
Food Chem Toxicol; 2006 Sep; 44(9):1449-54. PubMed ID: 16806627
[TBL] [Abstract][Full Text] [Related]
8. Biomonitoring of ochratoxin A in blood plasma and exposure assessment of adult students in Bangladesh.
Ali N; Blaszkewicz M; Manirujjaman M; Perveen R; Al Nahid A; Mahmood S; Rahman M; Hossain K; Degen GH
Mol Nutr Food Res; 2014 Nov; 58(11):2219-25. PubMed ID: 25164381
[TBL] [Abstract][Full Text] [Related]
9. Biomonitoring of Mycotoxins in Urine: Pilot Study in Mill Workers.
Föllmann W; Ali N; Blaszkewicz M; Degen GH
J Toxicol Environ Health A; 2016; 79(22-23):1015-1025. PubMed ID: 27924714
[TBL] [Abstract][Full Text] [Related]
10. Human biomonitoring of multiple mycotoxins in the Belgian population: Results of the BIOMYCO study.
Heyndrickx E; Sioen I; Huybrechts B; Callebaut A; De Henauw S; De Saeger S
Environ Int; 2015 Nov; 84():82-9. PubMed ID: 26233555
[TBL] [Abstract][Full Text] [Related]
11. Urinary ochratoxin A and ochratoxin alpha in pregnant women.
Klapec T; Sarkanj B; Banjari I; Strelec I
Food Chem Toxicol; 2012 Dec; 50(12):4487-92. PubMed ID: 23041474
[TBL] [Abstract][Full Text] [Related]
12. Evidence of ochratoxin A conjugates in urine samples from infants and adults.
Muñoz K; Cramer B; Dopstadt J; Humpf HU; Degen GH
Mycotoxin Res; 2017 Feb; 33(1):39-47. PubMed ID: 27830509
[TBL] [Abstract][Full Text] [Related]
13. Ochratoxin A in the morning and afternoon portions of urine from Coimbra and Valencian populations.
Manique R; Pena A; Lino CM; Moltó JC; Mañes J
Toxicon; 2008 Jun; 51(7):1281-7. PubMed ID: 18420246
[TBL] [Abstract][Full Text] [Related]
14. Utilising an LC-MS/MS-based multi-biomarker approach to assess mycotoxin exposure in the Bangkok metropolitan area and surrounding provinces.
Warth B; Petchkongkaew A; Sulyok M; Krska R
Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2014; 31(12):2040-6. PubMed ID: 25268629
[TBL] [Abstract][Full Text] [Related]
15. Blood plasma biomarkers of citrinin and ochratoxin A exposure in young adults in Bangladesh.
Ali N; Hossain K; Degen GH
Mycotoxin Res; 2018 Mar; 34(1):59-67. PubMed ID: 29143924
[TBL] [Abstract][Full Text] [Related]
16. Methods for analysis of citrinin in human blood and urine.
Blaszkewicz M; Muñoz K; Degen GH
Arch Toxicol; 2013 Jun; 87(6):1087-94. PubMed ID: 23354378
[TBL] [Abstract][Full Text] [Related]
17. Assessment of Exposure to Mycotoxins in Spanish Children through the Analysis of Their Levels in Plasma Samples.
Arce-López B; Lizarraga E; López de Mesa R; González-Peñas E
Toxins (Basel); 2021 Feb; 13(2):. PubMed ID: 33672088
[TBL] [Abstract][Full Text] [Related]
18. Survey of Canadian human blood plasma for ochratoxin A.
Scott PM; Kanhere SR; Lau BP; Lewis DA; Hayward S; Ryan JJ; Kuiper-Goodman T
Food Addit Contam; 1998 Jul; 15(5):555-62. PubMed ID: 9829040
[TBL] [Abstract][Full Text] [Related]
19. Automated high-throughput method using solid-phase microextraction-liquid chromatography-tandem mass spectrometry for the determination of ochratoxin A in human urine.
Vatinno R; Vuckovic D; Zambonin CG; Pawliszyn J
J Chromatogr A; 2008 Aug; 1201(2):215-21. PubMed ID: 18572176
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous LC-MS/MS determination of aflatoxin M1, ochratoxin A, deoxynivalenol, de-epoxydeoxynivalenol, α and β-zearalenols and fumonisin B1 in urine as a multi-biomarker method to assess exposure to mycotoxins.
Solfrizzo M; Gambacorta L; Lattanzio VM; Powers S; Visconti A
Anal Bioanal Chem; 2011 Nov; 401(9):2831-41. PubMed ID: 21892639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
